These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23345154)

  • 1. Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity.
    Kozu Y; Isaka M; Ohde Y; Takeuchi K; Nakajima T
    Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):191-4. PubMed ID: 23345154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
    Fu X; Jiang J; Tian XY; Li Z
    Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
    Liu Q; Kan Y; Zhao Y; He H; Kong L
    Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.
    Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
    Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
    Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
    Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
    Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
    Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
    Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
    Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
    Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
    Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.
    Zhou J; Jiang G; Zhang D; Zhang L; Xu J; Li S; Li W; Ma Y; Zhao A; Zhao Z
    Int J Clin Exp Pathol; 2015; 8(5):5803-7. PubMed ID: 26191301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
    Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
    Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelioid inflammatory myofibroblastic sarcomas are not exclusive to ventral cavity sites.
    Zilla ML; Khoshnoodi P; Bailey NG; Herradura A; Lee SJ; John I
    Histopathology; 2022 Feb; 80(3):610-612. PubMed ID: 34610169
    [No Abstract]   [Full Text] [Related]  

  • 14. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
    Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK
    Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.
    Du X; Gao Y; Zhao H; Li B; Xue W; Wang D
    Oncol Lett; 2018 Jun; 15(6):9317-9326. PubMed ID: 29805657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
    Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological features of inflammatory myofibroblastic tumor].
    Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
    [No Abstract]   [Full Text] [Related]  

  • 19. CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
    Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN
    Br J Cancer; 2020 Sep; 123(7):1101-1113. PubMed ID: 32684628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.